Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
The Brief Psychiatric Rating Scale
1962 • 10,683 citations
The Global Assessment Scale
1976 • 4,944 citations
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
1970 • 3,213 citations
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 • 3,182 citations
Recent advances in the phencyclidine model of schizophrenia
1991 • 2,886 citations
ECDEU Assessment Manual
1976 • 1,644 citations
Amelioration of negative symptoms in schizophrenia by glycine
1994 • 349 citations
Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
1989 • 216 citations
Excitatory Amino Acid Receptors in Schizophrenia
1993 • 90 citations
d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain
1991 • 63 citations
Glycine modulation of the phencyclidine binding site in mammalian brain
1988 • 63 citations
Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?
1992 • 62 citations
d-Cycloserine therapy of psychosis by symptom provocation
1970 • 42 citations
An NMDA Intervention Strategy in Schizophrenia With “Low-Dose” Milacemide
1991 • 37 citations
Cited By (0)
No citing papers found in database